Still, whatever the precise dollar figures, itâ€™s easy to see that   would become a de facto regime of price controls.   No industry wants that, of course, and neither should any   consumer. Yet all the details aside, Trump is on to something, politically, with his   bashing.   A 2016 survey by Edelman found that pharma ranks seventh in public esteem, out of the eight economic sectors surveyed the drugmakers came in ahead only of the   financial sector. 